| Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board |
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicine's Regional Dean for Seattle and Puget Sound's Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists (FACOG), and a Menopause Society Certified Practitioner (MSCP) – and Columbia University's Dr. Whitney Booker – a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine – to its Medical Advisory Board. “As Progyny continues to be at the forefront of women's health, we are proud to welcome two deeply respected clinical leaders whose unique training and lived experience will bring critical insights to our work,” said Dr. Janet Choi, Chief Medical Officer at Progyny. |
globenewswire.com |
2025-05-14 13:05:00 |
Czytaj oryginał (ang.) |
| Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference |
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time. |
globenewswire.com |
2025-05-12 19:58:00 |
Czytaj oryginał (ang.) |
| Progyny, Inc. (PGNY) Q1 2025 Earnings Call Transcript |
Progyny, Inc. (NASDAQ:PGNY ) Q1 2025 Results Conference Call May 8, 2025 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Pete Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities David Larsen - BTIG Sarah James - Cantor Fitzgerald Operator Good day, ladies and gentlemen, and welcome to the Progyny Inc. First Quarter 2025 Earnings Conference Call. At this time all participants are in a listen-only mode and the floor will be opened for questions and comments after the presentation. |
seekingalpha.com |
2025-05-09 00:05:02 |
Czytaj oryginał (ang.) |
| Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates |
Progyny (PGNY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.39 per share a year ago. |
zacks.com |
2025-05-08 23:55:39 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Announces First Quarter 2025 Results |
Reports Record Revenue of $324.0 Million, Reflecting 16.5% GrowthRaises Full Year Guidance Due to Strong Start to the YearEarly Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended March 31, 2025 (“the first quarter of 2025”) as compared to the three-month period ended March 31, 2024 (“the first quarter of 2024” or “the prior year period”). “We're pleased with the strong start to the year, highlighted by both our solid financial results as well as the progress made with our investments to expand the platform and extend our leading position as the solution of choice in women's health and family building,” said Pete Anevski, Chief Executive Officer of Progyny. |
globenewswire.com |
2025-05-08 20:14:00 |
Czytaj oryginał (ang.) |
| GDRX vs. PGNY: Which Stock Should Value Investors Buy Now? |
Investors looking for stocks in the Medical Services sector might want to consider either GoodRx Holdings, Inc. (GDRX) or Progyny (PGNY). But which of these two stocks is more attractive to value investors? |
zacks.com |
2025-05-08 16:40:29 |
Czytaj oryginał (ang.) |
| Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release |
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-05-01 15:06:39 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report |
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025. |
globenewswire.com |
2025-04-24 18:49:00 |
Czytaj oryginał (ang.) |
| Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again |
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-04-21 17:15:45 |
Czytaj oryginał (ang.) |
| Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer |
The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building |
globenewswire.com |
2025-04-17 13:36:00 |
Czytaj oryginał (ang.) |
| Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week® |
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges |
globenewswire.com |
2025-04-16 12:58:00 |
Czytaj oryginał (ang.) |
| The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building |
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing infertility, today announced the launch of their 2025 Awareness, Hope, and Activism (AHA) Grant, marking the fourth consecutive year of this family building partnership. |
globenewswire.com |
2025-04-08 12:57:00 |
Czytaj oryginał (ang.) |
| Progyny Expands Maternal Health Support with Addition of Doula Services |
Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes |
globenewswire.com |
2025-03-31 13:22:00 |
Czytaj oryginał (ang.) |
| Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering |
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation |
globenewswire.com |
2025-03-11 11:03:00 |
Czytaj oryginał (ang.) |
| Progyny, Inc. to Participate in Upcoming Investor Conferences |
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025. |
globenewswire.com |
2025-03-07 16:00:00 |
Czytaj oryginał (ang.) |
| PGNY CEO on "Well-Positioned" Sales Year & Expanding Footprint |
Pete Anevski, CEO of Progyny (PGNY), discusses his company's latest earnings and how it's poised for a "well-positioned" year. He notes general healthcare headwinds for the women's health company, though he expects Progyny to find new clients and retain current customers. |
youtube.com |
2025-03-03 15:20:18 |
Czytaj oryginał (ang.) |
| Progyny Tops EPS Forecast, Eyes Growth |
Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27. The standout points were its impressive revenue and adjusted earnings per share (EPS) results, both of which surpassed analysts' consensus predictions. |
fool.com |
2025-02-28 13:08:16 |
Czytaj oryginał (ang.) |
| Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript |
Progyny, Inc. (NASDAQ:PGNY ) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Leerink Partners John Pinney - Canaccord Genuity Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Allen Lutz - Bank of America Sarah James - Cantor Constantine Davides - Citizens JMP Jenny Shen - BTIG Operator Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call. |
seekingalpha.com |
2025-02-27 20:03:11 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Announces Fourth Quarter 2024 Results |
Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth |
globenewswire.com |
2025-02-27 18:01:00 |
Czytaj oryginał (ang.) |
| Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth |
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-20 13:06:20 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report |
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m. |
globenewswire.com |
2025-02-13 17:14:00 |
Czytaj oryginał (ang.) |
| Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm |
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. |
globenewswire.com |
2025-02-10 19:41:00 |
Czytaj oryginał (ang.) |
| All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy |
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
zacks.com |
2025-02-03 15:00:32 |
Czytaj oryginał (ang.) |
| Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? |
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-01-29 15:11:28 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump |
Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning |
globenewswire.com |
2025-01-28 10:44:00 |
Czytaj oryginał (ang.) |
| Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors |
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women's health benefits solution, today announced the appointment of 30-year healthcare industry veteran Debra Morris to its board of directors, effective January 16, 2025. |
globenewswire.com |
2025-01-16 11:00:00 |
Czytaj oryginał (ang.) |
| Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services |
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers. |
prnewswire.com |
2025-01-13 10:00:00 |
Czytaj oryginał (ang.) |
| Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm |
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. |
prnewswire.com |
2025-01-07 23:20:00 |
Czytaj oryginał (ang.) |
| The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying |
Progyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with strong fundamentals: $235M in cash, no debt, and 9.64% in trailing free cash flow yield. The stock's rare accumulation/momentum pattern since September and potential short squeeze kicker make it an attractive Buy. |
seekingalpha.com |
2024-12-30 22:17:28 |
Czytaj oryginał (ang.) |
| PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders |
SAN DIEGO , Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. |
prnewswire.com |
2024-12-18 22:33:00 |
Czytaj oryginał (ang.) |
| Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders |
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-12-18 12:42:00 |
Czytaj oryginał (ang.) |
| Robbins LLP Informs Progyny, Inc. Stockholders that it is Investigating the Officers and Directors of PGNY to Determine if They Breached Fiduciary Duties Owed to Shareholders |
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. |
globenewswire.com |
2024-12-12 00:38:00 |
Czytaj oryginał (ang.) |
| Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders |
SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-12-03 10:45:00 |
Czytaj oryginał (ang.) |
| Progyny: Rating Downgrade On Uncertain Growth Outlook |
I recommend downgrading Progyny from buy to hold due to a loss of confidence in its growth outlook and increased uncertainty. PGNY's Q3 2024 results were disappointing, with revenue and margins falling short of expectations, leading to lowered FY24 guidance. Declines in ART cycles and a weaker 2024 sales season raise concerns about underlying demand, despite potential upsides from upselling adjacent solutions. |
seekingalpha.com |
2024-11-26 09:54:16 |
Czytaj oryginał (ang.) |
| Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders |
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-11-18 13:25:00 |
Czytaj oryginał (ang.) |
| Progyny: After A Terrible Year, I'm Out (Rating Downgrade) |
I initially rated Progyny a "Buy" in late 2022, but 2024 has been disastrous, with a 60% stock drop and loss of Amazon as a client. Q3 2024 financials show minimal revenue growth, declining margins, and lower earnings per share, despite a strong balance sheet. Given management's struggles and increased competition, I no longer believe Progyny has a competitive advantage and have sold my shares. |
seekingalpha.com |
2024-11-18 01:47:22 |
Czytaj oryginał (ang.) |
| Progyny, Inc. to Present at Jefferies London Healthcare Conference |
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST). |
globenewswire.com |
2024-11-14 11:00:00 |
Czytaj oryginał (ang.) |
| Why Progyny Stock Crashed Today |
Why Progyny Stock Crashed Today |
fool.com |
2024-11-13 18:40:05 |
Czytaj oryginał (ang.) |
| These Analysts Slash Their Forecasts On Progyny Following Q3 Results |
Progyny, Inc. PGNY reported worse-than-expected third-quarter sales results and issued FY24 revenue guidance below estimates. |
benzinga.com |
2024-11-13 11:45:41 |
Czytaj oryginał (ang.) |
| Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript |
Progyny, Inc (NASDAQ:PGNY ) Q3 2024 Earnings Conference Call November 12, 2024 4:45 PM ET Company Participants James Hart - Investor Relations Peter Anevski - CEO Michael Sturmer - President Mark Livingston - CFO Conference Call Participants Anne Samuel - JPMorgan Allen Lutz - Bank of America Sarah James - Cantor Fitzgerald Michael Cherny - Leering Partners Glen Santangelo - Jefferies Jailendra Singh - Truist Securities Stephanie Davis - Barclays Scott Schoenhaus - KeyBanc Richard Close - Canaccord Genuity David Larsen - BTIG Operator Good day, and welcome to the Progyny, Inc. Third Quarter Earnings Conference Call. At this time all participants have been placed on listen-only mode. |
seekingalpha.com |
2024-11-12 22:15:02 |
Czytaj oryginał (ang.) |
| Progyny (PGNY) Tops Q3 Earnings Estimates |
Progyny (PGNY) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.16 per share a year ago. |
zacks.com |
2024-11-12 20:41:49 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Announces Third Quarter 2024 Results |
Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest Services in Maternity and/or Menopause Programs in 2025 |
globenewswire.com |
2024-11-12 18:02:00 |
Czytaj oryginał (ang.) |
| Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman |
SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the unexpected announcement of a major client's departure. |
globenewswire.com |
2024-11-08 11:20:00 |
Czytaj oryginał (ang.) |
| Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders |
SAN DIEGO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-11-08 10:50:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY |
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accesswire.com |
2024-11-04 18:45:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY |
NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
prnewswire.com |
2024-11-02 13:00:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY |
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accesswire.com |
2024-10-31 22:00:00 |
Czytaj oryginał (ang.) |
| Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report |
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended September 30, 2024 after the close of the market on Tuesday, November 12, 2024. |
globenewswire.com |
2024-10-29 16:00:00 |
Czytaj oryginał (ang.) |